Online pharmacy startup PillPack is raising new venture capital funding at around a $330 million pre-money valuation, Fortune has learned.
The Somerville, Mass.-based company on Tuesday disclosed via an SEC filing that it already has secured $31.1 million of a $40 million round, but multiple sources say that PillPack’s board has discussed increasing the overall raise to $50 million because of intense investor interest.
The Series D deal would represent an “up round” for PillPack, which raised $50 million in July 2015 at a pre-money valuation of nearly $240 million.
PillPack manages multiple prescription medications for customers, by pre-sorting, packaging and delivering the drugs—all with a 24/7 pharmacy team that can be contacted either online or via phone.
